TSE: 4503 · Health Technology
Which UK funds hold Astellas Pharma Inc. (4503)?
Astellas Pharma Inc. (4503) is among the ten largest holdings of 1 UK fund Fundology covers, according to the holdings each fund publishes. The largest weight is 3.21%, in JARI (Amundi MSCI Japan SRI Climate Paris Aligned ETF), as of 28/10/2026. In all, 133 funds list it among their published holdings. One swap-based fund also lists Astellas Pharma Inc. (4503) in the substitute basket it holds as collateral; it tracks a different index through a swap and is not counted as a holder.
UK funds that hold Astellas Pharma Inc.
Funds where it is one of the ten largest holdings, largest weight first. A weight is the share of the fund’s money in this company.
| Fund | Weight in the fund | Holdings as of |
|---|---|---|
| JARI · Amundi MSCI Japan SRI Climate Paris Aligned ETFLU2233156749 · one portfolio, 6 share classes | 3.21% |
Holdings dates differ by fund
Funds that hold it further down
132 more funds list Astellas Pharma Inc. below their ten largest holdings.
Create a free account to see every fund that holds this company, at any weight
Sign-up takes an email address. There is no card to enter and nothing to pay.
About Astellas Pharma Inc.
Astellas Pharma Inc. is listed on TSE under the symbol 4503, in the health technology sector. Its market value was about $28.7bn (in US dollars) on 30/10/2026.
A fund’s weight in a company is the share of the fund’s money held in that company’s shares. A weight of 5% in a fund worth £1 billion is about £50 million. Index funds hold companies in proportion to their size in the index, so the largest companies appear in many funds at similar weights.
The list above is drawn from the funds’ published holdings, each dated, and names the funds where Astellas Pharma Inc. is one of the ten largest holdings — the part of every fund page open to anyone. Some funds publish only their largest ten, so a fund can hold Astellas Pharma Inc. without it appearing in any list here. When two funds both hold the same large companies, owning both can be closer to owning one than it looks: the comparison page measures that overlap when both funds publish enough of their holdings.
Share price
- Latest price
- 2,571.00 JPY
- +2.31%on the day
- 52-week range
- 1,637.00 JPY–2,717.00 JPY
- Price change, 1 year
- +63.8%
- Price change, this year
- +22.2%
- Market value
- $28.7bn
- Price to earnings (12 months)
- 12.7
- Dividend yield (12 months)
- 3.14%
As of , at least 15 min delayed